Iphepha-intloko - 1

imveliso

I-Ticagrelor Newgreen Supply APIs 99% yeTicagrelor Powder

Inkcazelo emfutshane:

Igama leBrand: Newgreen

Inkcazo yeMveliso: 99%

Ubomi beShelf: 24month

Indlela yokuGcina: Indawo eyomileyo epholileyo

Imbonakalo: Umgubo omhlophe

Isicelo: Ishishini lezamayeza

Ukupakisha: 25kg / igubu; I-1kg / ibhegi yefoyile okanye iibhegi ezilungiselelwe wena


Iinkcukacha zeMveliso

Inkonzo ye-OEM/ODM

Iithegi zeMveliso

Ingcaciso yeMveliso

I-Ticagrelor yi-antiplatelet drug, i-P2Y12 i-receptor antagonist, esetyenziselwa ngokukodwa ukukhusela iziganeko ze-cardiovascular, ngakumbi kwizigulane ezine-acute coronary syndrome (ACS). Iyanciphisa umngcipheko we-thrombosis ngokuthintela ukuhlanganiswa kweplatelet.

Oomatshini abaphambili
Nqanda ukudityaniswa kweeplatelet:
I-Ticagrelor ibophelela ngokubuyisela kwi-P2Y12 i-receptor kwi-platelet surface, inqanda ukusebenza kweplatelet kunye nokuhlanganiswa okubangelwa yi-adenosine diphosphate (ADP), ngaloo ndlela inciphisa ukubunjwa kwe-thrombus.

Iimpawu
I-Ticagrelor isetyenziswa ikakhulu kwezi meko zilandelayo:
I-Acute Coronary Syndrome:Kubandakanya izigulane ezine-angina engazinzanga kunye ne-myocardial infarction, edla ngokusetyenziswa ngokudibanisa ne-aspirin ukunciphisa umngcipheko weziganeko ze-cardiovascular.
Uthintelo lwesibini lweziganeko zentliziyo:Kwizigulane esele zinesiganeko se-cardiovascular ukukhusela esinye.

I-COA

Izinto Iinkcukacha Iziphumo
Imbonakalo Umgubo omhlophe Iyahambelana
Umyalelo Uphawu Iyahambelana
Isivavanyi ≥99.0% 99.8%
Wangcamla Uphawu Iyahambelana
Ilahleko ekomisweni 4-7(%) 4.12%
IAsh iyonke 8% Ubuninzi 4.85%
Intsimbi enzima ≤10(ppm) Iyahambelana
Arsenic(As) 0.5ppm Ubuninzi Iyahambelana
Khokela(Pb) 1ppm Max Iyahambelana
IMercury(Hg) 0.1ppm Max Iyahambelana
Ukubalwa kwePleti iyonke 10000cfu/g Ubuninzi. 100cfu/g
Igwele kunye noMngundo 100cfu/g Ubuninzi. 20cfu/g
Salmonella Ibi Iyahambelana
E.Coli. Ibi Iyahambelana
Staphylococcus Ibi Iyahambelana
Ukuqukumbela Ufanelekile
Ugcino Gcina kwindawo evaliweyo kunye neqondo lokushisa eliphantsi rhoqo kwaye akukho kukhanya kwelanga ngqo.
Beka ubomi kwishelufa Iminyaka emi-2 xa igcinwe ngokufanelekileyo

Imiphumela

I-Ticagrelor ngokuqhelekileyo inyamezeleke kakuhle, kodwa ezinye iziphumo zecala zingenzeka, kuquka:

Ukopha:Esona siphumo sixhaphake kakhulu, esinokubangela ukopha okungephi okanye kubi kakhulu.

Ubunzima bokuphefumla:Ezinye izigulana zinokuba nobunzima bokuphefumla okanye ukukhohlela.

Iimpendulo zesisu:ezifana nesicaphucaphu, iintlungu zesisu okanye ukungagayi ngokwaneleyo.

Amanqaku

Umngcipheko Wokopha:Umngcipheko wokuphuma kwegazi kufuneka ubekwe iliso rhoqo xa usebenzisa i-Ticagrelor, ngakumbi xa isetyenziswe ngokuhambelana namanye amachiza e-anticoagulant.

Umsebenzi weHepatic:Ukusetyenziswa ngokuqaphela kwizigulane ezine-hepatic impairment; ukulungiswa kwethamo kunokufuneka.

Ukusebenzisana kweziyobisi:I-Ticagrelor inokusebenzisana namanye amachiza. Kufuneka uxelele ugqirha wakho malunga nazo zonke iziyobisi ozithathayo ngaphambi kokuba uyisebenzise.

Ukupakishwa kunye nokuhanjiswa

1
2
3

  • Ngaphambili:
  • Okulandelayo:

  • inkonzo ye-oemodm(1)

    Bhala umyalezo wakho apha kwaye uwuthumele kuthi